Overview of Cancer Control in Armenia and Policy Implications

Cancer is the second leading cause of death in Armenia. Over the past two decades, the country has seen a significant rise in cancer morbidity and mortality. This review aims to provide up-to-date info about the state of cancer control in Armenia and identify priority areas of research. The paper an...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 11; p. 782581
Main Authors Bedirian, Karen, Aghabekyan, Tigran, Mesrobian, Arianna, Shekherdimian, Shant, Zohrabyan, Davit, Safaryan, Liana, Sargsyan, Lilit, Avagyan, Armen, Harutyunyan, Lilit, Voskanyan, Astghik, Tadevosyan, Artashes, Melik-Nubaryan, Davit, Khachatryan, Parandzem, Saghatelyan, Tatul, Kostanyan, Mher, Vardevanyan, Hovhannes, Hovhannisyan, Marine, Sarkisian, Tamara, Sargsyan, Karine, Babikyan, Davit, Tananyan, Armen, Danielyan, Samvel, Muradyan, Armen, Tamamyan, Gevorg, Bardakhchyan, Samvel
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 11.01.2022
Subjects
cancer epidemiology
cancer policy
cancer prevention
cancer risk factors
cancer treatment
early detection of cancer
Oncology
Armenia
cancer treatment
cancer policy
cancer prevention
early detection of cancer
developing countries
cancer epidemiology
cancer risk factors
Online AccessGet full text

Cover

More Information
Summary:Cancer is the second leading cause of death in Armenia. Over the past two decades, the country has seen a significant rise in cancer morbidity and mortality. This review aims to provide up-to-date info about the state of cancer control in Armenia and identify priority areas of research. The paper analyzes published literature and local and international statistical reports on Armenia and similar countries to put numbers into context. While cancer detection, diagnosis, and treatment are improving, the prevalence of risk factors is still quite high and smoking is widespread. Early detection rates are low and several important screening programs are absent. Diagnosis and treatment methods are not standardized; there is a lack of treatment accessibility due to insufficient government coverage and limited availability of essential medicines. Overall, there is room for improvement in this sector, as research is limited and multidisciplinary approaches to the topic are rare.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Edited by: Paul Bernard Tchounwou, Jackson State University, United States
This article was submitted to Cancer Epidemiology and Prevention, a section of the journal Frontiers in Oncology
These authors have contributed equally to this work and share first authorship
Reviewed by: Xiaopan Li, Shanghai Pudong Disease Prevention and Control Center, China; Abdelbaset Mohamed Elasbali, Al Jouf University, Saudi Arabia
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2021.782581